Taiwan stores remdesivir vials for COVID-19 patients in critical condition

CECC addresses US control of remdesivir supplies, says Taiwan’s stockpile sufficient to treat 55 patients

Taiwan News
Date: 2020/07/03
By: Ching-Tse Cheng, Taiwan News, Staff Writer

Taiwan currently has 333 vials of remdesivir. (CNA photo)

TAIPEI (Taiwan News) — Taiwan's Central Epidemic Command Center (CECC) said Friday (July 3) that the country currently possesses 333 vials of remdesivir and will save them for emergency coronavirus treatment.

During a regular press conference to give Taiwan's pandemic update, CECC Spokesman Chuang Jen-hsiang (莊人祥) pointed out that the island nation's remdesivir stockpile is enough to treat 55 patients in serious or critical condition. He noted that the procurement of the antiviral drug is not urgent at the moment since Taiwan does not have patients in need of such treatment, reported CNA.

In response to global concerns that the U.S. has hoarded most of the world's remdesivir supplies, Chuang said the government will continue to negotiate with the Western superpower for a potential sale. Meanwhile, hospitals in Taiwan have other medications that can be relied on, he added.

Though it is not clear if remdesivir can improve survival rates, the drug has shown efficacy in shortening recovery time for severely ill coronavirus patients. It is also the first antiviral drug to be recommended by health officials in the European Union (EU) and approved by Japan.

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.